White Paper
Oncology Landscape: More Demand, Demands More
How data and insight-driven, orchestrated engagement can maximize sales in this highly competitive environment
May 28, 2020
U.S. spending on oncology is expected to increase by 11-14% over the next five years. Pharma companies that can deliver innovative new oncology drugs to market have the potential to generate significant revenue streams, but to do so, they need to incorporate five focus areas into their commercial planning process to differentiate their products and improve their revenue potential.